[HTML][HTML] Cumulative mechanisms of lymphoid tissue fibrosis and T cell depletion in HIV-1 and SIV infections

M Zeng, AJ Smith, SW Wietgrefe… - The Journal of …, 2011 - Am Soc Clin Investig
M Zeng, AJ Smith, SW Wietgrefe, PJ Southern, TW Schacker, CS Reilly, JD Estes, GF Burton
The Journal of clinical investigation, 2011Am Soc Clin Investig
The hallmark of HIV-1 and SIV infections is CD4+ T cell depletion. Both direct cell killing and
indirect mechanisms related to immune activation have been suggested to cause the
depletion of T cells. We have now identified a mechanism by which immune activation-
induced fibrosis of lymphoid tissues leads to depletion of naive T cells in HIV-1 infected
patients and SIV-infected rhesus macaques. The T regulatory cell response to immune
activation increased procollagen production and subsequent deposition as fibrils via the …
The hallmark of HIV-1 and SIV infections is CD4+ T cell depletion. Both direct cell killing and indirect mechanisms related to immune activation have been suggested to cause the depletion of T cells. We have now identified a mechanism by which immune activation-induced fibrosis of lymphoid tissues leads to depletion of naive T cells in HIV-1 infected patients and SIV-infected rhesus macaques. The T regulatory cell response to immune activation increased procollagen production and subsequent deposition as fibrils via the TGF-β1 signaling pathway and chitinase 3-like-1 activity in fibroblasts in lymphoid tissues from patients infected with HIV-1. Collagen deposition restricted T cell access to the survival factor IL-7 on the fibroblastic reticular cell (FRC) network, resulting in apoptosis and depletion of T cells, which, in turn, removed a major source of lymphotoxin-β, a survival factor for FRCs during SIV infection in rhesus macaques. The resulting loss of FRCs and the loss of IL-7 produced by FRCs may thus perpetuate a vicious cycle of depletion of T cells and the FRC network. Because this process is cumulative, early treatment and antifibrotic therapies may offer approaches to moderate T cell depletion and improve immune reconstitution during HIV-1 infection.
The Journal of Clinical Investigation